Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)»Diffuse large B-cell lymphoma (C83.3)
C83.3
Diffuse large B-cell lymphoma
Sub-codes (10)
- C83.30 Diffuse large B-cell lymphoma, unspecified site
- C83.31 Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck
- C83.32 Diffuse large B-cell lymphoma, intrathoracic lymph nodes
- C83.33 Diffuse large B-cell lymphoma, intra-abdominal lymph nodes
- C83.34 Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb
- C83.35 Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb
- C83.36 Diffuse large B-cell lymphoma, intrapelvic lymph nodes
- C83.37 Diffuse large B-cell lymphoma, spleen
- C83.38 Diffuse large B-cell lymphoma, lymph nodes of multiple sites
- C83.39 Diffuse large B-cell lymphoma, extranodal and solid organ sites
Related indications (MeSH) (2)
Lymphoma, Large B-Cell, Diffuse490 drugs (193 approved, 297 experimental)
Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
Plasmablastic Lymphoma24 drugs (18 approved, 6 experimental)
Malignant lymphoma composed of large B lymphoid cells which have the immunophenotype of plasma cells and a predilection for the ORAL CAVITY.